Spatial Biology: Hype or Hope?

Published on: 


Tuesday, November 15th, 2022 at 10 am EDT | 8 am CDT | 7 am PD Spatial Biology is changing the drug development landscape. Validating efficacy with and actual image of the molecule interacting with the tissue provides the additional data needed to determine success or failure. Join the webinar on November 15th to learn more about the solutions Spatial Biology provides.

Register free:

Event Overview:
Recent technological advancements have revolutionized our capacity to quantify cellular heterogeneity with spatial context, opening the doors to advanced studies with implications for drug development. This new and developing area, spatial biology goes beyond analyzing the drug’s impact on the targeted tissue, enabling the next generation of actionable clinical insights and could provide significant value to pharmaceutical companies.

Join this webinar to hear industry expert, Corinne Ramos, PhD., discuss exactly why Spatial Biology is not “hype”, but instead “hope” for drug development.

Key Learning Objectives:

  • How spatial biology:
    • Shows the complex ecosystem in the tissue microenvironment
    • Shows biomarker conceptualization and location
    • Shows cell interactions and their response to disease progression or on treatment
    • Examines spatial analysis for precision medicine


Corinne Ramos
Director of Research & Development

With more than 20 years of experience in leading innovative research and clinical programs, Corinne Ramos has extensively worked on the identification and development of biomarkers to predict therapeutic outcomes. She is known for driving clinical development to successful commercialization. She holds a Ph.D in Molecular Biology from the University Paul Sabatier in Toulouse, France and a MBA from the Johns Hopkins University-Carey Business School in Washington DC, USA

Register free: